Thalidomide May Prevent IgG4-RD Relapse Without Steroids

Thalidomide shows promise as a steroid-sparing option for IgG4-related disease, with a significant reduction in relapse rates and enhanced remission, according to a placebo-controlled study.
Medscape Medical News